;

© 2024, design with by 7awi Media Group

  • Homepage
  • Health ‏
  • Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld ‏

Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld

  • Publish date: Monday، 20 December 2021
Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld

Abu Dhabi has received the first global shipment of AstraZeneca’s COVID-19 long-acting antibody medication, Evusheld, after gaining emergency use authorisation from the UAE’s Ministry of Health and Prevention.

Evusheld, is designed to prevent severe infection and death amongst immunocompromised patients.

Read More: Worship places in Abu Dhabi

Read More: Abu Dhabi Entry Requirements Update

Read More: December Prayer Times In Abu Dhabi

The first doses of Evusheld arrived in Abu Dhabi on Monday following a collaboration of key partners including Rafed, the UAE’s Primary Group Purchasing Organisation, along with Etihad Cargo, AstraZeneca and Abu Dhabi Airports Company.

The breakthrough medication will be stored at Rafed’s distribution centre to be transported to various destinations.

Follow us on our Whatsapp channel for latest news
 

Related videos

Related articles